Myeloid Cell Reprogramming in Thyroid Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Thyroid Cancer
Related studies linked through entity extraction aliases.
Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Trial of PLA vs. Surgery for Treating PTMC
- Status
- UNKNOWN
- Phase
- NA
The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing Thyroidectomy
- Status
- UNKNOWN
- Phase
- NA
BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Project HERO: Health Empowerment & Recovery Outcomes
- Status
- COMPLETED
- Phase
- NA
Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography
- Status
- COMPLETED
- Phase
- N/A
The French E3N Prospective Cohort Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Intra-operative Rapid Identification of Lymph Node and Parathyroid
- Status
- UNKNOWN
- Phase
- NA
Nivolumab Plus Ipilimumab in Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer
- Status
- UNKNOWN
- Phase
- N/A
UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone
- Status
- SUSPENDED
- Phase
- PHASE2
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
- Status
- TERMINATED
- Phase
- PHASE4